TRIM65 and hepatocellular carcinoma: To validate the oncogenic role of Trim65 in vivo, we established another HCC model by intraperitoneally injecting diethylnitrosamine (DEN) and carbon tetrachloride (CCl4) (DEN/CCl4) at indicated timepoints (Figure 2F).